1.Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer
Jang Ho LEE ; Eun Young KIM ; Cheol-Kyu PARK ; Shin Yup LEE ; Min ki LEE ; Seong-Hoon YOON ; Jeong Eun LEE ; Sang Hoon LEE ; Seung Joon KIM ; Sung Yong LEE ; Jun Hyeok LIM ; Tae-Won JANG ; Seung Hun JANG ; Kye Young LEE ; Seung Hyeun LEE ; Sei Hoon YANG ; Dong Won PARK ; Chan Kwon PARK ; Hye Seon KANG ; Chang Dong YEO ; Chang-Min CHOI ; Jae Cheol LEE
Cancer Research and Treatment 2023;55(1):112-122
Purpose:
Although osimertinib is the standard-of-care treatment of epidermal growth factor receptor (EGFR) T790M mutation–positive non–small cell lung cancer, real-world evidence on the efficacy of osimertinib is not enough to reflect the complexity of the entire course of treatment. Herein, we report on the use of osimertinib in patients with EGFR T790M mutation–positive non–small cell lung cancer who had previously received EGFR tyrosine kinase inhibitor (TKI) treatment in Korea.
Materials and Methods:
Patients with confirmed EGFR T790M after disease progression of prior EGFR-TKI were enrolled and administered osimertinib 80 mg daily. The primary effectiveness outcome was progression-free survival, with time-to-treatment discontinuation, treatment and adverse effects leading to treatment discontinuation, and overall survival being the secondary endpoints.
Results:
A total of 558 individuals were enrolled, and 55.2% had investigator-assessed responses. The median progression-free survival was 14.2 months (95% confidence interval [CI], 13.0 to 16.4), and the median time-to-treatment discontinuation was 15.0 months (95% CI, 14.1 to 15.9). The median overall survival was 36.7 months (95% CI, 30.9 to not reached). The benefit with osimertinib was consistent regardless of the age, sex, smoking history, and primary EGFR mutation subtype. However, hepatic metastases at the time of diagnosis, the presence of plasma EGFR T790M, and the shorter duration of prior EGFR-TKI treatment were poor predictors of osimertinib treatment. Ten patients (1.8%), including three with pneumonitis, had to discontinue osimertinib due to severe adverse effects.
Conclusion
Osimertinib demonstrated its clinical effectiveness and survival benefit for EGFR T790M mutation–positive in Korean patients with no new safety signals.
2.Awareness and Use of Complementary and Alternative Medicine in Korean Lung Cancer Patients
Joon Young CHOI ; Wonjun JI ; Chang-Min CHOI ; Chaeuk CHUNG ; Jae Myoung NOH ; Cheol-Kyu PARK ; In-Jae OH ; Hong In YOON ; Hyeong Ryul KIM ; Ho Young KIM ; Chang Dong YEO ; Seung Hun JANG ;
Tuberculosis and Respiratory Diseases 2021;84(2):105-114
Background:
Complementary and alternative medicine (CAM) has been used frequently, and its use continues to increase in lung cancer patients, despite insufficient scientific of its efficacy. To investigate this situation, we analyzed the current awareness and use of CAM in Korean lung-cancer patients. Methods: This prospective survey–based study was performed at seven medical centers in South Korea between August and October 2019. The survey assessed general patient characteristics and the awareness and use of CAM. We analyzed differences in the clinical parameters of patients aware and not aware of CAM and of CAM non-users and users.
Results:
Of the 434 patients included in this study, 68.8% responded that they were aware of CAM and 30.9% said they had experienced it. In univariate analysis, the patients aware of CAM were younger with poor performance status, had advanced-stage lung cancer, received more systemic therapy, and received concurrent chemoradiation therapy (CCRT). By multiple logistic regression, younger age, poor performance status, advanced stage, and prior CCRT were identified as independent risk factors for CAM awareness. There were no significant differences in the general characteristics and cancer-associated clinical parameters of CAM non-users and users.
Conclusion
Specific clinical parameters were associated with patients’ awareness of CAM, although there were no significantly different characteristics between CAM users and non-users.
3.Simultaneous determination of fourteen components of Gumiganghwal-tang tablet in human plasma by UPLC-ESI-MS/MS and its application to pharmacokinetic study
Jeong SEUNG-HYUN ; Jang JI-HUN ; Lee GUK-YEO ; Yang SEUNG-JUNG ; Cho HEA-YOUNG ; Lee YONG-BOK
Journal of Pharmaceutical Analysis 2021;11(4):444-457
Gumiganghwal-tang is a traditional herbal medicine widely used for its anti-inflammatory,analgesic,and antipyretic effects.However,the safety and efficacy of its active ingredients based on an in vivo pharmacokinetic (PK) study have yet been investigated.We have established a sensitive and accurate UPLC-ESI-MS/MS method and conducted a PK study on 14 constituents of Gumiganghwal-tang through human plasma analysis.Analytical conditions were optimized according to the physicochemical prop-erties of the 14 compounds to facilitate efficient separation and eliminate overlap or interference be-tween peaks.KINETEX-C18 and lnertsil-C8 columns were used as UPLC stationary phases,and acetonitrile and aqueous formic acid were used as mobile phases.All the analytes were quantified with a triple quadrupole mass spectrometer using electrospray ionization in multiple reaction monitoring mode.The chromatograms of 14 bioactive compounds showed excellent elution and sensitivity,and each peak was selectively separated and quantified without interference with each other or impurities.The established analytical method was based on international guidelines and was successfully used to perform PK studies of 14 herbal ingredients in humans after oral administration with Gumiganghwal-tang tablets.The oral absorption of most active components of Gumiganghwal-tang was relatively rapid and remained considerably long in the body to be quantified in plasma up to 48 h after administration.
4.Development of Korean Teaching Model for Surgical Procedures in Trauma -Essential Surgical Procedures in Trauma Course-
Hohyun KIM ; Chan Yong PARK ; Hyun Min CHO ; Kwang Hee YEO ; Jae Hun KIM ; Byungchul YU ; Seung Je GO ; Oh Sang KWON
Journal of the Korean Society of Traumatology 2019;32(1):8-16
PURPOSE:
The Essential Surgical Procedures in Trauma (ESPIT) course was developed as a model to teach necessary surgical procedures to trauma physicians. Its goals are to improve knowledge, self-confidence, and technical competence.
METHODS:
The ESPIT course consisted of five lectures and a porcine lab operative experience. The ESPIT course has been run seven times between February 2014 and April 2016. ESPIT participants completed a questionnaire to assess self-efficacy regarding essential surgical procedures in trauma before and immediately after taking the ESPIT course. Sixty-three participants who completed both pre- and post-course questionnaires on self-efficacy were enrolled in this study.
RESULTS:
The overall post-ESPIT mean self-efficacy score was higher than the pre-ESPIT mean self-efficacy score (8.3±1.30 and 4.5±2.13, respectively) (p<0.001). Self-efficacy was significantly improved after the ESPIT course in general surgeons (p<0.001), thoracic and cardiovascular surgeons (p<0.001), emergency medicine doctors, and others (neurosurgeons, orthopedic surgeons) (p<0.001). The differences in self-efficacy score according to career stage (<1 year, 1–3 years, 3–5 years, and >5 years) were also statistically significant (p<0.001).
CONCLUSIONS
The data of the ESPIT participants indicated that they felt that the ESPIT course improved their self-efficacy with regard to essential surgical procedures in trauma. The ESPIT course may be an effective strategy for teaching surgical procedures, thus promoting better management of traumatic injuries.
5.Measurement of the Exposed Eyeball Area and Vertical Dimension of Palpebral Fissure after Double Eyelidplasty.
Archives of Aesthetic Plastic Surgery 2017;23(1):24-29
BACKGROUND: Although the technique of double eyelidplasty is well recognized, there have been a few reports on the measurement of the eyelid after the operation. Herein, we measured the changes of the eyelids photogrammatically and compared them with others. METHODS: Database of patients who had undergone double eyelidplasty using a three-partial-incision technique, along with a follow-up of more than 6 months, were identified. The changes of eyelid were measured by exposed eyeball area (EEA) and vertical dimension of palpebral fissure (VDPF) using preoperative and postoperative photographs. RESULTS: Between January 2012 and December 2013, there were 28 patients who were followed-up for more than 6 months. All patients were female between the age of 16 and 37 years; the average follow-up period was 11.4 months. The mean preoperative value of EEA was 74.6±9.1% and that of VDPF was 7.4±1.0 mm. Conversely, the mean postoperative value of EEA was 83.9±6.3% and that of VDPF was 8.5±1.0 mm. CONCLUSIONS: The mean values of EEA and VDPF after double eyelidplasty had changed with statistical significance.
Blepharoplasty
;
Eyelids
;
Female
;
Follow-Up Studies
;
Humans
;
Vertical Dimension*
6.Early Complications from Absorbable Anchoring Suture Following Thread-Lift for Facial Rejuvenation.
Seung Hun YEO ; Young Bae LEE ; Dong Gil HAN
Archives of Aesthetic Plastic Surgery 2017;23(1):11-16
BACKGROUND: Thread lifting has been known as a minimally invasive procedure compared with the standard incisional surgery for facial rejuvenation. Although there have been several reports on acute or delayed complications after using nonabsorbable thread type, there have only been a few studies on such complications after using absorbable thread type. Hence, the aim of this study was to introduce various complications of thread lifting using the absorbable anchoring type for facial rejuvenation and to discuss about how to resolve it. METHODS: A retrospective review of 144 cosmetic patients, who underwent absorbable barbed thread lifting between July 2013 and December 2015, was performed. The procedure was done using the temporal anchoring technique. The thread used in this study are polydioxanone molding cog (PMC) and polydioxanone cutting cog (PCC), which are both the absorbable type. RESULTS: The results are as follows: Dimple was developed in 3 cases (2.1%); thread exposure was developed in 5 cases (3.5%); alopecia was developed in 3 cases (2.1%); undercorrection was developed in 3 cases (2.1%); asymmetry was developed in 1 case (0.7%); and parotid gland injury was developed in 1 case (0.7%). Out of the total 144 patients, sixteen (11.1%) patients developed at least 1 complication. There was no detectable inflammation or consistent skin excavation. CONCLUSIONS: Most complications of absorbable thread lifting are minor ones, and such complications resolve by retouching or widening the anchoring gap, but it is important to keep in mind the possibility of parotid gland injury.
Alopecia
;
Fungi
;
Humans
;
Inflammation
;
Lifting
;
Parotid Gland
;
Polydioxanone
;
Rejuvenation*
;
Retrospective Studies
;
Rhytidoplasty
;
Skin
;
Suture Anchors
;
Sutures*
7.Effect of the amount of thickness reduction on color and translucency of dental monolithic zirconia ceramics.
Hee Kyung KIM ; Sung Hun KIM ; Jai Bong LEE ; Jung Suk HAN ; In Sung YEO ; Seung Ryong HA
The Journal of Advanced Prosthodontics 2016;8(1):37-42
PURPOSE: This study investigated the effect of amount of thickness reduction on color and translucency of dental monolithic zirconia ceramics. MATERIALS AND METHODS: One-hundred sixty-five monolithic zirconia specimens (16.3 mm x 16.3 mm x 2.0 mm) were divided into 5 groups (Group I to V) according to the number of A2-coloring liquid applications. Each group was then divided into 11 subgroups by reducing the thickness up to 1.0 mm in 0.1-mm increments (Subgroup 0 to 10, n=3). Colors and spectral distributions were measured according to CIELAB on a reflection spectrophotometer. All measurements were performed on five different areas of each specimen. Color difference (DeltaE*(ab)) and translucency parameter (TP) were calculated. Data were analyzed using one-way ANOVA and multiple comparison Scheffe test (alpha=.05). RESULTS: There were significant differences in CIE L* between Subgroup 0 and other subgroups in all groups. CIE a* increased (0.52
Ceramics*
;
Prosthesis Coloring
8.Patient's Factors at Entering Hospice Affecting Length of Survival in a Hospice Center.
Guk Jin LEE ; Hye Shin AHN ; Se Eun GO ; Ji Hyun KIM ; Min Wu SEO ; Seung Hun KANG ; Yeo Ree YANG ; Mi Yeong LEE ; Ku Ock LEE ; Sang Hoon CHUN ; Jong Youl JIN
Cancer Research and Treatment 2015;47(1):1-8
PURPOSE: In order to provide effective hospice care, adequate length of survival (LOS) in hospice is necessary. However the reported average LOS is much shorter. Analysis of LOS in hospice has not been reported from Korea. We evaluated the duration of LOS and the factors associated with LOS at our hospice center. MATERIALS AND METHODS: We retrospectively examined 446 patients who were admitted to our hospice unit between January 2010 and December 2012. We performed univariate and multivariate analysis for analysis of factors associated with LOS. RESULTS: The median LOS was 9.5 days (range, 1 to 186 days). The LOS of 389 patients (86.8%) was< 1 month. At the time of admission to hospice, 112 patients (25.2%) were completely bedridden, 110 patients (24.8%) had mouth care only without intake, and 134 patients (30.1%) had decreased consciousness, from confusion to coma. The median time interval between the day of the last anticancer treatment and the day of hospice admission was 75 days. By analysis of the results of multivariate analysis, decreased intake and laboratory results showing increased total white blood cell (WBC), decreased platelet count, increased serum creatinine, increased aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) level were poor prognostic factors for survival in hospice. CONCLUSION: Before hospice admission, careful evaluation of the patient's performance, particularly the oral intake, and total WBC, platelet, creatinine, AST, ALT, and LDH level is essential, because these were strong predictors of shorter LOS. In the future, conduct of prospective controlled studies is warranted in order to confirm the relationship between potential prognostic factors and LOS in hospice.
Alanine Transaminase
;
Aspartate Aminotransferases
;
Blood Platelets
;
Coma
;
Consciousness
;
Creatinine
;
Hospice Care
;
Hospices*
;
Humans
;
Korea
;
L-Lactate Dehydrogenase
;
Leukocytes
;
Mouth
;
Multivariate Analysis
;
Platelet Count
;
Prognosis
;
Retrospective Studies
;
Survival Analysis
9.Effect of working time on the film thickness of dental resin cements.
Yu Seung YI ; Sung Hun KIM ; Jai Bong LEE ; Jung Suk HAN ; In Sung YEO ; Seung Ryong HA ; Hee Kyung KIM
The Journal of Korean Academy of Prosthodontics 2015;53(4):325-329
PURPOSE: The aim of this study was to compare the film thicknesses of several resin cements as a function of time after mixing and to examine the effect of working time on the film thicknesses. MATERIALS AND METHODS: The film thickness (microm) of 4 resin cements (n=10), 1 composite resin (Panavia F 2.0), 3 self-adhesive resin (Clearfil SA luting, Zirconite, RelyX U200) cements was measured at 20-second intervals after mixing of the cements up to 200 seconds under a load of 50 N. Linear regression was fitted to verify the effect of working time on the film thickness of each cement. Data were compared to the working time recommended by manufacturers using Wilcoxon test (alpha=.05). RESULTS: All of the materials showed a positive linear correlation between the film thickness and working time. There was no statistically significant difference between the working time based on our results and the values recommended by the manufacturers even though there was a discrepancy between those two values. CONCLUSION: The film thickness of resin cements could increase with the increase of working time. Working time to meet the ISO standard of 50-microm maximum film thickness could be different from the manufacturer's recommended value.
Linear Models
;
Resin Cements
;
Resins, Synthetic*
10.Prevention of Venous Thromboembolism, 2nd Edition: Korean Society of Thrombosis and Hemostasis Evidence-Based Clinical Practice Guidelines.
Soo Mee BANG ; Moon Ju JANG ; Kyoung Ha KIM ; Ho Young YHIM ; Yeo Kyeoung KIM ; Seung Hyun NAM ; Hun Gyu HWANG ; Sung Hwa BAE ; Sung Hyun KIM ; Yeung Chul MUN ; Yang Ki KIM ; Inho KIM ; Won Il CHOI ; Chul Won JUNG ; Nan Hee PARK ; Nam Kyong CHOI ; Byung Joo PARK ; Doyeun OH
Journal of Korean Medical Science 2014;29(2):164-171
In 2010, we proposed the first Korean Guidelines for the Prevention of Venous Thromboembolism (VTE). It was applicable to Korean patients, by modifying the contents of the second edition of the Japanese guidelines for the prevention of VTE and the 8th edition of the American College of Chest Physicians (ACCP) evidence-based clinical practice guidelines. From 2007 to 2011, we conducted a nationwide study regarding the incidence of VTE after major surgery using the Health Insurance Review and Assessment Service (HIRA) database. In addition, we have considered the 9th edition of the ACCP Evidenced-Based Clinical Practice Guidelines, published in 2012. It emphasized the importance of clinically relevant events as opposed to asymptomatic outcomes with preferences for both thrombotic and bleeding outcomes. Thus, in the development of the new Korean guidelines, three major points were addressed: 1) the new guidelines stratify patients into 4 risk groups (very low, low, moderate, and high) according to the actual incidence of symptomatic VTE from the HIRA databases; 2) the recommended optimal VTE prophylaxis for each group was modified according to condition-specific thrombotic and bleeding risks; 3) guidelines are intended for general information only, are not medical advice, and do not replace professional medical care and/or physician advice.
Age Factors
;
Anticoagulants/adverse effects/*therapeutic use
;
Asian Continental Ancestry Group
;
Evidence-Based Medicine
;
Heparin, Low-Molecular-Weight/therapeutic use
;
Humans
;
*Mechanical Thrombolysis
;
Neoplasms/complications/surgery
;
Republic of Korea
;
Risk Assessment
;
Surgical Procedures, Operative/adverse effects
;
Venous Thromboembolism/etiology/prevention & control/*therapy

Result Analysis
Print
Save
E-mail